Pfizer Inc and Moderna Inc has raised the prices of its COVID-19 vaccine in the latest European Union supply contracts, The Financial Times reported on Sunday.
For the latest headlines, follow our Google News channel online or via the app.
The new price for the Pfizer shot was 19.50 euros ($23.15) against 15.50 euros previously, the newspaper said citing to the portions of the contracts seen.
The price of a Moderna vaccine was $25.50 a dose, the contracts show, up from 19 euros in the first procurement deal but lower than the previously agreed $28.50 because the order had grown, the report said, citing one official close to the matter.
Read the latest updates in our dedicated coronavirus section.
Read more:
Chinese cities roll out mass testing for millions amid surge in COVID-19 cases
France expects 50 million foreign tourists this summer: Minister
Possible MERS-like COVID-19 strain that could kill 1 in 3 infected people: Study
Also Read
-
Risk of blood clots in Pfizer COVID-19 vaccine as likely as AstraZeneca jab: Study
The Pfizer-BioNTech COVID-19 vaccine is just as likely as the AstraZeneca jab to cause blood clots, a Lancet study has found. For more coronavirus ... Coronavirus -
Italian regulators approve Moderna’s COVID-19 vaccine for 12-17 year olds
Italian regulators approved the use of Moderna’s COVID-19 vaccine for children 12-17 years old, making it the second shot endorsed for adolescents, ... Coronavirus -
Pfizer, Moderna to expand COVID-19 vaccine study to kids ages 5 – 11
Moderna Inc is in talks with US regulators to expand the size of an ongoing trial testing its COVID-19 vaccines in children aged between five and 11, ... Coronavirus
